Literature DB >> 9381361

[Preoperative irradiation and interstitial radiotherapy-hyperthermia boost in breast tumors > or = 3 cm. The Düsseldorf experience].

K A Hartmann1, W Audretsch, U M Carl, S Gripp, C Kolotas, K Muskalla, M Rezai, T Schnabel, I Waap, N Zamboglou, G Schmitt.   

Abstract

AIM: The aim of this protocol was to investigate breast conservation rates with and without flap-supported surgery after preoperative chemotherapy, radiotherapy and hyperthermia. PATIENTS AND METHODS: One hundred and fifty-eight patients with stage IIA-IV breast cancers were initially treated with chemotherapy, radiotherapy and hyperthermia. Radiation treatment consisted of an interstitial boost of 10 Gy 192Ir-afterloading therapy and a course of external beam radiotherapy of 50 Gy, using 5 x 2 Gy/week. Local hyperthermia with 43.5-44.5 degrees C over 60 minutes was delivered immediately before interstitial radiotherapy.
RESULTS: One hundred and forty-two patients underwent salvage surgery. A breast-conserving approach was possible in 74 patients (52%). Fifty-three patients (37%) underwent flap-supported surgery. After a median follow-up of 20 months, one patient developed isolated local recurrence. In 14 cases, locoregional recurrences occurred in combination with distant metastases.
CONCLUSION: In about 50%, breast conservation was achieved by chemotherapy, radiotherapy and hyperthermia. The low isolated local recurrence rate of 0.6% (1/158) has to be substantiated by further follow-up.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9381361     DOI: 10.1007/bf03038468

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

1.  External irradiation prior to conservative surgery for breast cancer treatment.

Authors:  E Calitchi; Y Otmezguine; F Feuilhade; P Piedbois; J M Pavlovitch; B Brun; J J Mazeron; J P Le Bourgeois; M Julien; B Pierquin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

2.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.

Authors:  G Bonadonna; U Veronesi; C Brambilla; L Ferrari; A Luini; M Greco; C Bartoli; G Coopmans de Yoldi; R Zucali; F Rilke
Journal:  J Natl Cancer Inst       Date:  1990-10-03       Impact factor: 13.506

3.  Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.

Authors:  S M Scholl; A Fourquet; B Asselain; J Y Pierga; J R Vilcoq; J C Durand; T Dorval; T Palangié; M Jouve; P Beuzeboc
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

4.  Local control of operable breast cancer after radiotherapy alone.

Authors:  E Van Limbergen; E Van der Schueren; W Van den Bogaert; J Van Wing
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

5.  Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation.

Authors:  F A Zoetmulder; J H Borger; E J Rutgers; R Bergman; J Peterse; H Bartelink
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Combination of external and interstitial irradiation in the primary management of breast carcinoma.

Authors:  A M Syed; A Puthawala; P Fleming; D Neblett; R A Gowdy; K M Sheikh; F W George; D Eads; C McNamara
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

Review 7.  Multidisciplinary management of advanced primary and metastatic breast cancer.

Authors:  G N Hortobagyi
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

8.  Conservation surgery after primary chemotherapy in large carcinomas of the breast.

Authors:  U Veronesi; G Bonadonna; S Zurrida; V Galimberti; M Greco; C Brambilla; A Luini; S Andreola; F Rilke; R Raselli
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

  8 in total
  4 in total

1.  Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy.

Authors:  Stephan Ludwig Roth; Werner Audretsch; Hans Bojar; Innokentij Lang; Reinhart Willers; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2010-05-21       Impact factor: 3.621

2.  Thermal boost combined with interstitial brachytherapy in breast conserving therapy - Assessment of early toxicity.

Authors:  Adam Chicheł; Janusz Skowronek; Marek Kanikowski
Journal:  Rep Pract Oncol Radiother       Date:  2011-04-08

3.  Thermal Boost to Breast Tumor Bed-New Technique Description, Treatment Application and Example Clinical Results.

Authors:  Adam Chicheł; Wojciech Burchardt; Artur J Chyrek; Grzegorz Bielęda; Grzegorz Zwierzchowski; Patrycja Stefaniak; Julian Malicki
Journal:  Life (Basel)       Date:  2022-03-30

4.  Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.

Authors:  Jan Haussmann; Wilfried Budach; Carolin Nestle-Krämling; Sylvia Wollandt; Balint Tamaskovics; Stefanie Corradini; Edwin Bölke; David Krug; Tanja Fehm; Eugen Ruckhäberle; Werner Audretsch; Danny Jazmati; Christiane Matuschek
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.